Kyntra Bio, Inc.
KYNB· Nasdaq
Filed May 9, 2016 · 10-Q · 39 days after period end · 0001564590-16-018598
| Metric | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|
| Revenue | $28.28M | $16.30M | $17.88M |
| Net Income | -$27.84M | -$46.37M | -$16.24M |
| EPS Diluted | -$0.45 | -$0.78 | -$1.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 9, 2016 · 39 d after period end